PTEN and neoplasm: So far, hundreds of mutations in PTEN have been identified [8, 9], and inactivating PTEN protein has been shown to lead to uninhibited phosphorylation of Akt, resulting in dysregulation of the mTOR pathway that is responsible for tumor survival, proliferation, and apoptosis [10, 11].